Success Metrics

Clinical Success Rate
95.6%

Based on 218 completed trials

Completion Rate
96%(218/228)
Active Trials
48(13%)
Results Posted
9%(19 trials)
Terminated
10(3%)

Phase Distribution

Ph not_applicable
300
84%
Ph phase_3
10
3%
Ph phase_1
5
1%
Ph phase_2
13
4%

Phase Distribution

5

Early Stage

13

Mid Stage

10

Late Stage

Phase Distribution328 total trials
Phase 1Safety & dosage
5(1.5%)
Phase 2Efficacy & side effects
13(4.0%)
Phase 3Large-scale testing
10(3.0%)
N/ANon-phased studies
300(91.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

92.8%

218 of 235 finished

Non-Completion Rate

7.2%

17 ended early

Currently Active

48

trials recruiting

Total Trials

357

all time

Status Distribution
Active(66)
Completed(218)
Terminated(17)
Other(56)

Detailed Status

Completed218
unknown53
Recruiting35
Not yet recruiting15
Active, not recruiting13
Terminated10

Development Timeline

Analytics

Development Status

Total Trials
357
Active
48
Success Rate
95.6%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (1.5%)
Phase 213 (4.0%)
Phase 310 (3.0%)
N/A300 (91.5%)

Trials by Status

completed21861%
active_not_recruiting134%
terminated103%
unknown5315%
withdrawn72%
enrolling_by_invitation31%
recruiting3510%
not_yet_recruiting154%
suspended31%

Recent Activity

Clinical Trials (357)

Showing 20 of 357 trialsScroll for more
NCT02425345Not Applicable

Women's Health Initiative Strong and Healthy Study

Completed
NCT05896852Not Applicable

Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV

Completed
NCT07173166Not Applicable

Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy

Recruiting
NCT02153957Phase 2

Trial Evaluating an Enhanced Physical Activity Intervention to Improve Cognitive Late Effects in Children Treated With Cranial Radiation for Brain Tumors

Completed
NCT07710274Not Applicable

Effectiveness of the Personalized Responses & Integrated Systems for Metabolism (PRISM) on Improving Insulin Resistance Among Adults With Metabolic Syndrome: A Pilot Study (PRISM-I)

Not Yet Recruiting
NCT05980052Not Applicable

Goal Setting to Promote Physical Activity Adherence in Midlife Adults

Recruiting
NCT06124339Not Applicable

Brain Health Virtual Reality Study

Active Not Recruiting
NCT06822387Not Applicable

Health Without Barriers/Salud Sin Barreras- Northern Colorado

Active Not Recruiting
NCT06493214Not Applicable

Interrupting Prolonged Sitting With ACTivity (InPACT) at Home Optimization Study

Completed
NCT06640179Not Applicable

Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)

Recruiting
NCT02567591Not Applicable

Adapted Physical Activity Effect on Aerobic Function and in Patients in Pre Liver Transplantation

Completed
NCT07659392Not Applicable

Physical Activity and Cardiometabolic Health in Women With or Without Polycystic Ovary Syndrome (SCOPAP)

Not Yet Recruiting
NCT04298086Phase 2

A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer

Active Not Recruiting
NCT05132296Not Applicable

Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer

Active Not Recruiting
NCT07599241Not Applicable

Additive Efficacy of Physical Activity Program in Hypthyroidism Elder Females With Glaucoma and Fatty Liver Issues

Recruiting
NCT06376656Not Applicable

Successful Aging and Age-related Decline

Active Not Recruiting
NCT07581106

Physical Activity During Pregnancy in Women With Pre-existing Diabetes

Not Yet Recruiting
NCT07569809Not Applicable

Protein-Enriched Food Multi-Mix Impact on Nutritional Status of Community-Residing Older Adults

Completed
NCT06423963Not Applicable

Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer

Recruiting
NCT07415720Not Applicable

Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.

Recruiting

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
357